2023 Annual Meeting of the American Academy of Allergy, Asthma & Immunology (AAAAI)

Location: San Antonio, TX

Dates: February 24-27, 2023

Posters:

EPIPHAST Part 3 AAAAI 2023 Oppenheimer final

Poster Title:  IMPACT OF FOOD EXPOSURE ON THE PHARMACOKINETICS OF EPINEPHRINE SUBLINGUAL FILM
Poster Number: 7
Presentation Time: Friday February 24th 3:15-4:15 PM
Lead Author: John Oppenheimer, M.D., UMDNJ Rutgers University School of Medicine

EPIPHAST Part 3 AAAAI 2023 Bernstein final

Poster Title:   PHARMACOKINETICS OF EPINEPHRINE SUBLINGUAL FILM FOLLOWING THREE DIFFERENT ADMINISTRATION PROCEDURES
Poster Number: 17
Presentation Time: Friday February 24th 3:15-4:15 PM
Lead Author: David Bernstein M.D., University of Cincinnati College of Medicine

EPIPHAST Part 2 AAAAI 2023 Golden final

Poster Title:  PHARMACOKINETICS AND PHARMACODYNAMICS OF EPINEPHRINE SUBLINGUAL FILM VERSUS INTRA-MUSCULAR EPINEPHRINE
Poster Number: 12
Presentation Time: Friday February 24th 3:15-4:15 PM
Lead Author: David Golden M.D., Medstar Franklin Square Hospital

EPIPHAST II AAAAI 2023 Greenhawt final

Poster Title:   COMPARISON OF THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILES OF EPINEPHRINE DELIVERED BY A SUBLINGUALLY ABSORBED FILM VERSUS 0.3 MG ADMINISTERED BY A STANDARD IM INJECTION OR THE EPIPEN®
Poster Number: L13
Presentation Time: Friday February 24th 3:15-4:15 PM
Lead Author: Matthew Greenhawt, M.D., MBA, MSc, Children's Hospital Colorado

Please complete this form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing info@aquestive.com or by calling 1-908-941-1900.
  • This field is for validation purposes and should be left unchanged.

Please complete the form below and click SEND to receive a copy of “Overcoming Solubility and Permeability Challenges,” a case study detailing the achievements made by Aquestive’s formulation team to create the diazepam buccal film.

  • To subscribe to receive marketing updates about diazepam buccal film and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form to receive a demonstration kit for our PharmFilm® technology.

  • To subscribe to receive marketing updates about our PharmFilm® technology and other products and services from Aquestive, please complete the form below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete this form:

  • To subscribe to receive marketing updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. If for any reason you no longer wish to receive information on Aquestive-sponsored clinical trials, you can contact us at any time by emailing clinicaltrials@aquestive.com.

Whether we are partnering to out license our PharmFilm® technology or in-licensing adjacent assets, Aquestive works hand-in-hand with our partners to address their toughest clinical and business challenges. To learn more, please complete the following form:

  • To subscribe to receive information updates about products and services from Aquestive Therapeutics, or to receive information about Aquestive-sponsored clinical trials, please check the box below. Please also review our privacy policy, which describes how we use and process your data. You may also contact us at any time by emailing busdev@aquestive.com.

Please complete the form below and click submit to receive a copy of “The Art of LGS Book.”

Please complete our short form to speak with a business development specialist.